Siddhartha Mondragon-Rodriguez, PhD - Publications

Affiliations: 
CINVESTAV, Mexico 

19 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Mondragón-Rodríguez S, Salgado-Burgos H, Peña-Ortega F. Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis. Neural Plasticity. 2020: 2960343. PMID 32952546 DOI: 10.1155/2020/2960343  0.32
2018 Mondragón-Rodríguez S, Gu N, Fasano C, Peña-Ortega F, Williams S. dFunctional connectivity between Hippocampus and Lateral septum is affected in very young Alzheimer's transgenic mouse model. Neuroscience. PMID 30599271 DOI: 10.1016/J.Neuroscience.2018.12.042  0.84
2018 Mondragón-Rodríguez S, Gu N, Manseau F, Williams S. Alzheimer's Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition. Frontiers in Cellular Neuroscience. 12: 121. PMID 29867356 DOI: 10.3389/Fncel.2018.00121  0.84
2018 Mondragón Rodríguez S, Salas Gallardo A, Gonzalez Pereyra P, Macías M, Ordaz B, Peña Ortega F, Aguilar Vazquez A, Orta Salazar E, Díaz Cintra S, Perry G, Williams S. Phosphorylation of tau protein correlates with changes in hippocampal theta oscillations and reduces hippocampal excitability in Alzheimer's model. The Journal of Biological Chemistry. PMID 29632073 DOI: 10.1074/Jbc.Ra117.001187  0.72
2016 Mahar I, Albuquerque MS, Mondragon-Rodriguez S, Cavanagh C, Davoli MA, Chabot JG, Williams S, Mechawar N, Quirion R, Krantic S. Phenotypic Alterations in Hippocampal NPY- and PV-Expressing Interneurons in a Presymptomatic Transgenic Mouse Model of Alzheimer's Disease. Frontiers in Aging Neuroscience. 8: 327. PMID 28154533 DOI: 10.3389/Fnagi.2016.00327  0.84
2016 Mondragón-Rodríguez S, Perry G, Peña-Ortega F, Williams S. Tau, Amyloid beta and Deep brain stimulation: Aiming to restore cognitive deficit in Alzheimer's disease. Current Alzheimer Research. PMID 27539594 DOI: 10.2174/1567205013666160819131336  0.84
2015 Zhang F, Su B, Wang C, Siedlak SL, Mondragon-Rodriguez S, Lee HG, Wang X, Perry G, Zhu X. Posttranslational modifications of α-tubulin in alzheimer disease. Translational Neurodegeneration. 4: 9. PMID 26029362 DOI: 10.1186/S40035-015-0030-4  0.84
2014 Mondragón-Rodríguez S, Perry G, Luna-Muñoz J, Acevedo-Aquino MC, Williams S. Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer's disease and Down syndrome. Neuropathology and Applied Neurobiology. 40: 121-35. PMID 24033439 DOI: 10.1111/Nan.12084  0.84
2013 Mondragón-Rodríguez S, Perry G, Zhu X, Moreira PI, Acevedo-Aquino MC, Williams S. Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer's disease. Oxidative Medicine and Cellular Longevity. 2013: 940603. PMID 23936615 DOI: 10.1155/2013/940603  0.84
2012 Mondragón-Rodríguez S, Trillaud-Doppia E, Dudilot A, Bourgeois C, Lauzon M, Leclerc N, Boehm J. Interaction of endogenous tau protein with synaptic proteins is regulated by N-methyl-D-aspartate receptor-dependent tau phosphorylation. The Journal of Biological Chemistry. 287: 32040-53. PMID 22833681 DOI: 10.1074/Jbc.M112.401240  0.84
2012 Mondragón-Rodríguez S, Perry G, Zhu X, Moreira PI, Williams S. Glycogen synthase kinase 3: a point of integration in Alzheimer's disease and a therapeutic target? International Journal of Alzheimer's Disease. 2012: 276803. PMID 22779025 DOI: 10.1155/2012/276803  0.84
2012 Mondragón-Rodríguez S, Perry G, Zhu X, Boehm J. Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy. International Journal of Alzheimer's Disease. 2012: 630182. PMID 22482074 DOI: 10.1155/2012/630182  0.76
2011 Mondragon-Rodriguez S, Burgeois C, Boehm J. Tau phosphorylation links Amyloid beta and NMDA receptor activation, implications for Alzheimer's disease Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.09.068  0.76
2011 Collins GH, Mondragón-Rodríguez S, Nunomura A, Zhu X, Moreira PI, Smith MA. Oxidative Stress and Balance in Neurodegenerative Diseases Neurodegeneration: the Molecular Pathology of Dementia and Movement Disorders: Second Edition. 10-12. DOI: 10.1002/9781444341256.ch3  0.84
2010 Mondragón-Rodríguez S, Basurto-Islas G, Lee HG, Perry G, Zhu X, Castellani RJ, Smith MA. Causes versus effects: the increasing complexities of Alzheimer's disease pathogenesis. Expert Review of Neurotherapeutics. 10: 683-91. PMID 20420489 DOI: 10.1586/Ern.10.27  0.76
2009 Mondragón-Rodríguez S, Basurto-Islas G, Binder LI, García-Sierra F. Conformational changes and cleavage; are these responsible for the tau aggregation in Alzheimer's disease? Future Neurology. 4: 39-53. DOI: 10.2217/14796708.4.1.39  0.76
2008 García-Sierra F, Mondragón-Rodríguez S, Basurto-Islas G. Truncation of tau protein and its pathological significance in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 14: 401-9. PMID 18688090 DOI: 10.3233/Jad-2008-14407  0.72
2008 Mondragón-Rodríguez S, Basurto-Islas G, Santa-Maria I, Mena R, Binder LI, Avila J, Smith MA, Perry G, García-Sierra F. Cleavage and conformational changes of tau protein follow phosphorylation during Alzheimer's disease. International Journal of Experimental Pathology. 89: 81-90. PMID 18336525 DOI: 10.1111/J.1365-2613.2007.00568.X  0.76
2008 Mondragón-Rodríguez S, Mena R, Binder LI, Smith MA, Perry G, García-Sierra F. Conformational changes and cleavage of tau in Pick bodies parallel the early processing of tau found in Alzheimer pathology. Neuropathology and Applied Neurobiology. 34: 62-75. PMID 17971079 DOI: 10.1111/J.1365-2990.2007.00853.X  0.76
Show low-probability matches.